2. Lipids
  3. Glycerophospholipids
  4. Phosphatidylcholines (PC)

Phosphatidylcholines (PC)

Phosphatidylcholines (PC) (186):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-W040193
    DSPC 816-94-4 99.95%
    DSPC (1,2-Distearoyl-sn-glycero-3-phosphorylcholine) is a cylindrical-shaped lipid. DSPC is used to synthesize liposomes, and is the lipid component in the lipid nanoparticle (LNP) system.
    DSPC
  • HY-108635
    C16-PAF 74389-68-7 99.86%
    C16-PAF (PAF (C16)), a phospholipid mediator, is a platelet-activating factor and ligand for PAF G-protein-coupled receptor (PAFR). C16-PAF exhibits anti-apoptotic effect and inhibits caspase-dependent death by activating the PAFR. C16-PAF is a potent MAPK and MEK/ERK activator. C16-PAF induces increased vascular permeability.
    C16-PAF
  • HY-113424A
    1,2-Dioleoyl-sn-glycero-3-phosphocholine 4235-95-4 99.93%
    1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC) is a phospholipid and is commonly used alone, or with other components, in the generation of micelles, liposomes, and other types of artificial membranes.
    1,2-Dioleoyl-sn-glycero-3-phosphocholine
  • HY-109506
    DPPC 63-89-8 99.91%
    DPPC (129Y83) is a phosphoglyceride that can be used to prepare lipid monolayers, bilayers, and liposomes. DPPC is the main lipid component of pulmonary surfactant. Dppc-liposome can be effectively used as a delivery vector to induce an immune response against GSL antigen in mice.
    DPPC
  • HY-139414
    Lysophosphatidylcholines 9008-30-4 99.9%
    Lysophosphatidylcholines is an orally active lysolipid and a component of oxidized low density lipoprotein (LDL). Lysophosphatidylcholines induces cell injury, the production of IL-1β and apoptosis. Lysophosphatidylcholines has a proactive effect on sepsis.
    Lysophosphatidylcholines
  • HY-113029
    LysoPC (20:3(5Z,8Z,11Z)) 1199257-41-4
    LysoPC 20:3(5Z,8Z,11Z) is a lysophosphatidylcholine. LysoPC 20:3(5Z,8Z,11Z) can be used as a biomarker for acute aortic dissection.
    LysoPC (20:3(5Z,8Z,11Z))
  • HY-113001
    LysoPC(20:3(8Z,11Z,14Z)/0:0) 1006703-11-2
    LysoPC (20:3 (8Z,11Z,14Z)/0:0) is a bioactive lysophosphatidylcholine. LysoPC (20:3 (8Z,11Z,14Z)/0:0) is applicable to research related to inflammation and autoimmune diseases.
    LysoPC(20:3(8Z,11Z,14Z)/0:0)
  • HY-N11605
    PC 16:0/18:1 65877-71-6
    PC 16:0/18:1
  • HY-130462
    1-Palmitoyl-2-oleoyl-sn-glycero-3-PC 26853-31-6 99.96%
    1-Palmitoyl-2-oleoyl-sn-glycero-3-PC (POPC), a phospholipid, is a major component of biological membranes. 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC is used for the preparation of liposomes and studying the properties of lipid bilayers.
    1-Palmitoyl-2-oleoyl-sn-glycero-3-PC
  • HY-125783
    1-Palmitoyl-sn-glycero-3-phosphocholine 17364-16-8 99.92%
    1-Palmitoyl-sn-glycero-3-phosphocholine (16:0 Lyso PC) is an abundant lysophosphatidylcholine. 1-Palmitoyl-sn-glycero-3-phosphocholine exhibits proinflammatory activity. 1-Palmitoyl-sn-glycero-3-phosphocholine can be used in the study of atherosclerosis.
    1-Palmitoyl-sn-glycero-3-phosphocholine
  • HY-109541
    Colfosceril miristate 18194-24-6 99.96%
    Colfosceril miristate (DMPC) is a synthetic phospholipid. Colfosceril miristate has antiproliferative effects on various tumors. Colfosceril miristate is used to study lipid monolayers, bilayers and drug delivery.
    Colfosceril miristate
  • HY-N9410
    Lysophosphatidylcholine 18:2 22252-07-9 99.12%
    Lysophosphatidylcholine 18:2 (1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC), a lysophospholipid, is a potential biomarker identified from insulin resistance (IR) polycystic ovary syndrome (PCOS). Low plasma Lysophosphatidylcholine 18:2 also has been shown to predict impaired glucose tolerance, insulin resistance, type 2 diabetes, coronary artery disease, and memory impairment.
    Lysophosphatidylcholine 18:2
  • HY-125771
    1-Stearoyl-sn-glycero-3-phosphocholine 19420-57-6 99.53%
    1-Stearoyl-sn-glycero-3-phosphocholine is a lysophosphatidylcholine that inhibits HDAC3 activity and phosphorylation of STAT3 in K562 cells. 1-Stearoyl-sn-glycero-3-phosphocholine induces apoptosis and exhibits anticancer activity in chronic myelogenous leukemia (CML) K562 cells.
    1-Stearoyl-sn-glycero-3-phosphocholine
  • HY-113123
    LysoPC(14:0/0:0) 20559-16-4 99.84%
    LysoPC(14:0/0:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. LysoPC(14:0/0:0) has potent antispasmodic effect.
    LysoPC(14:0/0:0)
  • HY-W140439
    1-Oleoyl-sn-glycero-3-phosphocholine 19420-56-5 99.58%
    1-Oleoyl-sn-glycero-3-phosphocholine (18:1 Lyso PC), a lysophospholipid, is a GPR82 inhibitor. 1-Oleoyl-sn-glycero-3-phosphocholine abrogates constitutive Gi-coupled GPR82 activity, shifts active/inactive equilibrium to inactive, suppresses Gi protein activation, increases cAMP production, and decreases GTPγS binding to Gαi proteins. 1-Oleoyl-sn-glycero-3-phosphocholine contributes to adipocyte lipolysis regulation.1-Oleoyl-sn-glycero-3-phosphocholine exhibits reduced serum levels in mouse models of steatohepatitis, linked to hepatic Lpcat 1-4 up-regulation.
    1-Oleoyl-sn-glycero-3-phosphocholine
  • HY-107737
    1,2-DLPC 18194-25-7 98.0%
    1,2-DLPC (1,2-Dilauroyl-sn-glycero-3-phosphocholine) is a ligand for LRH-1 agonists. 1,2-DLPC is a phospholipid used in the synthesis of liposomes. 1,2-DLPC enhances fat breakdown and apoptosis in fat cells through a TNFα-dependent pathway, while also inhibiting palmitate-induced insulin resistance through PPARα-mediated inflammation in muscle cells.
    1,2-DLPC
  • HY-116013
    Dodecylphosphocholine 29557-51-5 99.97%
    Dodecylphosphocholine is a detergent widely utilized in NMR studies of membrane proteins.
    Dodecylphosphocholine
  • HY-141570
    Lyso-PAF C-16 52691-62-0 99.84%
    Lyso-PAF C-16 is a precursor and metabolite of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (PAF C-16). Lyso-PAF C-16 is a substrate for either PAF C-16 formation by the remodeling pathway or selective acylation with arachidonic acid by a CoA-independent transacylase.
    Lyso-PAF C-16
  • HY-W440982
    SOPC 56421-10-4 99.86%
    SOPC (PC (18:0/18:1)) is a phosphatidylcholine lipid, which is an unsaturated phospholipid containing a cis double bond. When SOPC binds to Imatinib (HY-15463), Imatinib easily penetrates into its unsaturated liposome bilayer structure, and SOPC forms ordered, larger parallel stripe domains.
    SOPC
  • HY-141616
    1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine 50930-23-9 99.97%
    1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine is an endogenous metabolite present in Blood that can be used for the research of Pregnancy and Sepsis.
    1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine